These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6231598)

  • 1. [Bone and blood levels of azlocillin after intra-arterial injection in the dog].
    Millart H; Choisy H; Lamiable D; Choisy C
    Presse Med; 1984 Mar; 13(13):802-4. PubMed ID: 6231598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacokinetics of azlocillin].
    Singlas E; Haegel C
    Presse Med; 1984 Mar; 13(13):788-96. PubMed ID: 6231596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Azlocillin--a new anti-pseudomonas penicillin. A review of the literature and pharmacokinetic studies].
    Modr Z; Dvorácek K; Janků I; Krebs V
    Infection; 1982; 10 Suppl 3():S184-90. PubMed ID: 7152688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mezlocillin concentrations in human bone tissue].
    Vent J
    Arzneimittelforschung; 1979; 29(12a):1969-71. PubMed ID: 543904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous azlocillin kinetics in patients on long-term hemodialysis.
    Aletta JM; Francke EF; Neu HC
    Clin Pharmacol Ther; 1980 Apr; 27(4):563-6. PubMed ID: 7357815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
    Naber K; Adam D
    Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies.
    Delgado FA; Stout RL; Whelton A
    J Antimicrob Chemother; 1983 May; 11 Suppl B():79-88. PubMed ID: 6619035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose.
    Naber KG; Adam D
    J Antimicrob Chemother; 1983 May; 11 Suppl B():115-20. PubMed ID: 6619021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of azlocillin and mezlocillin by the normal pancreas and in acute pancreatitis in dogs and rats.
    Demol P; Singer MV; Bernemann D; Linzenmeier G; Goebell H
    Digestion; 1983; 27(2):93-9. PubMed ID: 6628842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of azlocillin in patients with biliary t-tube drainage.
    Gundert-Remy U; Weber E
    Eur J Clin Pharmacol; 1982; 22(5):435-9. PubMed ID: 7117356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of azlocillin in children with cystic fibrosis.
    Bergan T; Michalsen H
    Arzneimittelforschung; 1979; 29(12a):1955-7. PubMed ID: 543899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the excretion of azlocillin with bronchial secretion in children (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Arzneimittelforschung; 1979; 29(12a):1952-4. PubMed ID: 543898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of peripheral elimination on the concentration-effect relationship of remifentanil in anaesthetized dogs.
    Kabbaj M; Vachon P; Varin F
    Br J Anaesth; 2005 Mar; 94(3):357-65. PubMed ID: 15653707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of azlocillin in the burn patient].
    Drugeon HB; Pannier M; Courtieu AL
    Presse Med; 1984 Mar; 13(13):805-7. PubMed ID: 6231599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacocinetics of azlocillin (author's transl)].
    Mester U; Hartwig H; Krasemann C; Stein HJ
    Klin Monbl Augenheilkd; 1979 Feb; 174(2):219-24. PubMed ID: 439698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.